Pages that link to "Q34534439"
Jump to navigation
Jump to search
The following pages link to Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease (Q34534439):
Displaying 50 items.
- Standard therapy of advanced Hodgkin lymphoma (Q22299211) (← links)
- Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma (Q24234975) (← links)
- Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma (Q24240697) (← links)
- Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma (Q24240753) (← links)
- Cooperative epigenetic modulation by cancer amplicon genes (Q24608701) (← links)
- Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors (Q24683022) (← links)
- Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 years (Q26829198) (← links)
- Search algorithms as a framework for the optimization of drug combinations (Q28474246) (← links)
- The European Hematology Association Roadmap for European Hematology Research: a consensus document (Q28830861) (← links)
- Hodgkin lymphoma, version 2.2015. (Q30769157) (← links)
- Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). (Q31155582) (← links)
- Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel. (Q33297034) (← links)
- Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma (Q33373091) (← links)
- Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma (Q33379431) (← links)
- Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation (Q33400803) (← links)
- GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma (Q33411127) (← links)
- ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma (Q33432027) (← links)
- ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacy (Q33432165) (← links)
- Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. (Q33442092) (← links)
- A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment (Q33712928) (← links)
- Role of chemotherapy in Hodgkin's lymphoma (Q33761103) (← links)
- Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience (Q33974210) (← links)
- Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma (Q34095620) (← links)
- Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? (Q34185759) (← links)
- Advanced hodgkin lymphoma: a new era of therapy (Q34194160) (← links)
- Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma (Q34235785) (← links)
- Hodgkin's lymphoma therapy: past, present, and future (Q34296914) (← links)
- The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials (Q34352408) (← links)
- Hodgkin disease-an ever-evolving therapy (Q34463426) (← links)
- Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography (Q34495333) (← links)
- A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). (Q34553446) (← links)
- Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)? (Q34583406) (← links)
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial (Q34637268) (← links)
- Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort study (Q34653591) (← links)
- Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis (Q34655407) (← links)
- Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management (Q34662648) (← links)
- BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group (Q34707420) (← links)
- A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration (Q34766672) (← links)
- Modelling chemotherapy effects on granulopoiesis (Q34996295) (← links)
- Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells (Q35007967) (← links)
- Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma (Q35038832) (← links)
- The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future (Q35038852) (← links)
- Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma (Q35051886) (← links)
- Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group Study (Q35104961) (← links)
- Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma (Q35602142) (← links)
- Part II: Hodgkin's lymphoma--diagnosis and treatment (Q35618783) (← links)
- Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial (Q35671369) (← links)
- Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma (Q35705317) (← links)
- Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature (Q35789387) (← links)
- PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway (Q35833989) (← links)